Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · February 10, 2024

Efficacy of Immunosuppressive Therapy in Patients With Cardiac Sarcoidosis and Active Myocardial Inflammation

JACC: Cardiovascular Imaging


Additional Info

Disclosure statements are available on the authors' profiles:

JACC: Cardiovascular Imaging
Prospective Analysis of Immunosuppressive Therapy in Cardiac Sarcoidosis With Fluorodeoxyglucose Myocardial Accumulation: The PRESTIGE Study
JACC Cardiovasc Imaging 2024 Jan 01;17(1)45-58, R Morimoto, K Unno, N Fujita, Y Sakuragi, T Nishimoto, M Yamashita, T Kuwayama, H Hiraiwa, T Kondo, Y Kuwatsuka, T Okumura, S Ohshima, H Takahashi, M Ando, H Ishii, K Kato, T Murohara

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading